Researchers at Mass General Brigham have uncovered an unexpected benefit hiding inside one of America's most prescribed medications: older veterans taking statins were 24% less likely to develop frailty, suggesting these cholesterol-lowering drugs may help people preserve strength and independence as they age.
Frailty—a medical condition marked by muscle loss, fatigue, slow walking speed, and low activity levels—has become increasingly common among older Americans. The condition is particularly consequential because frail older adults face a dramatically heightened risk of functional decline even after minor illnesses or injuries. Until now, there have been no approved medications specifically designed to prevent it, leaving doctors with few tools to help aging patients maintain their health and autonomy.
The study, led by cardiologist Saadia Qazi, DO, MPH, MSc, of VA Boston and Mass General Brigham's Division of Aging, analyzed nearly a million older veterans to understand how statins might play a protective role. Between 2002 and 2018, researchers tracked 987,301 U.S. veterans aged 67 and older who were initially non-frail and not taking statins. Over an average follow-up period of 5.3 years, about 290,729 veterans began statin therapy while more than 636,000 developed frailty. Using a validated 31-item Veterans Affairs Frailty Index, the team found that statin use was associated with substantially lower risk of frailty even after accounting for body mass index, sex, race, smoking status, cardiovascular disease, cancer, and other health factors.
The protective effect was remarkably consistent. Veterans across many subgroups—those in older age brackets, people with diabetes, cardiovascular disease, arthritis, or dementia—all showed the same reduced risk. Perhaps most striking, the benefit appeared even among people who were "pre-frail" at the study's start, meaning statins helped prevent frailty even when started relatively late in life, not years before symptoms might appear.
Scientists believe statins work beyond their well-known cholesterol-lowering effects. The drugs carry potent anti-inflammatory properties that may slow the biological processes underlying aging and functional decline. Because frailty and heart disease share overlapping biological mechanisms, targeting these common pathways could potentially prevent both conditions, according to senior author Ariela Orkaby, MD, MPH, a geriatrician at VA Boston and Mass General Brigham.
"There are currently no approved medications specifically to prevent frailty," Qazi said in a statement. "Our findings suggest that statins may offer an important opportunity to reduce the risk of frailty and help people preserve their health and independence as they age."
The research, published in the European Heart Journal, represents a significant shift in how we think about medications developed for one purpose—lowering cholesterol—potentially serving another. While researchers emphasize that randomized clinical trials are needed to confirm these findings, the scale and consistency of this observational study of nearly one million people suggests statins deserve closer examination as a tool in the broader effort to help older adults maintain strength, mobility, and independence. For millions of aging Americans already taking statins for heart health, the possibility that these drugs might simultaneously protect against frailty offers a hopeful glimmer of an unexpected benefit.